Gopal Snacks will host virtual one-on-one meetings with institutional investors and analysts on August 24, 2026. The snack food manufacturer confirmed the schedule in a filing dated August 19, 2026, disclosing engagements with Axis AIF, Chrys Capital, and DSP Mutual Fund.

The interactions are scheduled as virtual sessions. The company emphasized that no unpublished price-sensitive information (UPSI) will be disclosed during these meetings.

Meeting Details

The company notified both BSE Limited and National Stock Exchange of India regarding the upcoming engagements. The schedule is subject to change due to exigencies on the part of the analysts, investors, or the company.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mayur Gangani, Head – Legal & Compliance and Company Secretary, signed the intimation.

Gopal Snacks Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ending March 31, 2026, marking a foundational step in its sustainability disclosure journey. The company identified FY26 as the baseline year for defining and monitoring key ESG parameters, including carbon emissions, energy efficiency, waste management, and water stewardship. Consequently, no specific performance targets were set or measured against during this period, as the primary objective was to establish robust data systems and identify priority areas for future improvement.

The Rajkot-based snack manufacturer reported a total turnover of ₹15,082.26 million and a net worth of ₹4,788.00 million for FY26. These financial figures triggered the applicability of Corporate Social Responsibility (CSR) provisions under Section 135 of the Companies Act, 2013. The report, which forms an integral part of the annual report, was signed by Company Secretary Mayur Gangani and filed with both the Bombay Stock Exchange and the National Stock Exchange on August 17, 2026.

Operational Scope and Workforce

Gopal Snacks operates through four manufacturing plants and one office across India, serving customers in 13 states domestically and nine countries internationally. Despite its global reach, export contribution remains minimal at 0.11% of total turnover. The company’s workforce consists of 4,115 individuals, comprising 1,455 permanent employees and 2,687 permanent workers.

Women representation stands at 25% on the Board of Directors but is 0% among Key Managerial Personnel (KMPs). Among permanent employees, females constitute 9.83% of the headcount, while they make up 31.96% of permanent workers.

Sustainability and Governance Focus

The company highlighted product quality and safety as a critical risk area, emphasizing compliance with FSSAI standards and managing allergen-related sensitivities. To mitigate these risks, Gopal Snacks has implemented digitized quality assurance processes and rigorous vendor evaluations. Environmental Health and Safety (EHS) management is viewed as a strategic enabler, with structured controls to reduce operational disruptions and regulatory penalties.

Supply chain resilience is another key focus, with the company adopting direct sourcing from farmers and Agricultural Produce Market Committees (APMCs) to reduce dependence on single-source suppliers. This approach aims to improve price competitiveness and traceability while strengthening local connections.

What the Numbers Show

The divergence between the company’s extensive domestic distribution network (13 states) and its negligible export contribution (0.11%) underscores a highly localized revenue model. This concentration suggests that Gopal Snacks’ growth trajectory and risk profile are predominantly tied to domestic consumer trends and regional supply chain dynamics, rather than global market fluctuations.

Compliance and Certifications

Gopal Snacks holds certifications from the Food Safety and Standards Authority of India (FSSAI), HALAL, APEDA, and the US FDA. The company maintains an anti-bribery policy with zero tolerance for corruption and ensures 100% coverage of training programs for employees on ethical conduct and safety protocols. No fines, penalties, or imprisonment actions were reported against directors or key managerial personnel during the fiscal year.